Navigation Links
Stiefel Laboratories, Inc. Appoints New President
Date:2/29/2008

CORAL GABLES, Fla., Feb. 29 /PRNewswire/ -- Stiefel Laboratories, Inc. has announced the promotion of William D. (Bill) Humphries to president of the privately-held dermatology company. Stiefel's board of directors elected Humphries to the position at its February 26 meeting. This move marks the first time in the organization's 160-year history that a non-family member has held the position of president.

"This promotion is testament to the board's trust in Bill's proven ability to serve as both an effective and dynamic leader of this company," said Charles W. Stiefel, chairman of the board and CEO, Stiefel Laboratories. "Bill's leadership abilities and extensive pharmaceutical experience will serve the company well as we continue our upward trajectory to achieving our corporate objective of $1 billion in sales next fiscal year. I look forward to working side-by-side with Bill and the rest of our senior executive team as we strive to be the world's most-valued and respected dermatology-focused specialty pharmaceutical company."

As president, Humphries will continue to lead all sales, marketing, strategic communications, public relations and commercial aspects of Stiefel's global business. He also will assume responsibility for Glades Pharmaceuticals, a wholly-owned subsidiary of Stiefel specializing in the sales and marketing of generic pharmaceutical products. This additional responsibility will provide increased flexibility to engage in lifecycle management of Stiefel products.

In his prior position as chief commercial officer, Humphries orchestrated the creation of an integrated global commercial team; helped oversee Stiefel's 2006 acquisition of Connetics Corporation; and played a key role in the 2007 private equity minority investment agreement between Stiefel Laboratories and The Blackstone Group. He was appointed to the company's board of directors in 2006.

Humphries is a 20-year veteran of the pharmaceutical industry, with 18 of those years focused on the specialty of dermatology. He was a vice president at Allergan, Inc., and also worked with Dermik/Rhone-Poulenc-Rorer.

Humphries holds a Bachelor of Arts from Bucknell University in Lewisburg, Pa. and an MBA from Pepperdine University in Malibu, Calif. He also holds seats on the boards of BioSouth and the Gwinnett County (Georgia) Chamber of Commerce, and the board of trustees for Georgia Gwinnett College.

Humphries will continue to work out of the company's global sales and marketing headquarters in Duluth, Ga.

About Stiefel Laboratories, Inc.

Founded in 1847, Stiefel Laboratories (a privately held company) is the world's largest independent pharmaceutical company specializing in dermatology. The company manufactures and markets a variety of prescription and non-prescription dermatological products. Some of the newest and best- known brands include Duac(R) (clindamycin, 1% - benzoyl peroxide, 5%) Care System (CS); Evoclin(R) (clindamycin phosphate, 1%) Foam; Luxiq(R) (betamethasone valerate, 0.12%) Foam; MimyX(R); Olux(TM) (clobetasol propionate, 0.05%) Foam; Olux-E(TM) (clobetasol propionate, 0.05%) Foam; Soriatane(R) (acitretin) CK CONVENIENCE KIT(TM); Verdeso(TM) (desonide, 0.05%) Foam; Brevoxyl(R) (benzoyl peroxide, 4% or 8%) Creamy Wash packaged in the convenient new BREVOXYL Acne Wash Kit; Extina(R) (ketoconazole, 2%) Foam; Oilatum(R); Physiogel(R); Stieprox(R) (ciclopirox olamine); REVALESKIN(TM); and Sarna(R). Its wholly-owned global network is comprised of more than 30 subsidiaries, manufacturing plants in six countries, research and development facilities on four continents, and products marketed in more than 100 countries around the world.

Stiefel Laboratories supplements its R&D efforts by seeking strategic partnerships and acquisitions around the world. To learn more about Stiefel Laboratories, Inc. visit http://www.stiefel.com.


'/>"/>
SOURCE Stiefel Laboratories, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Metaglip(R)
2. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic OTC Versions of Childrens Zyrtec(R) Chewable Tablets for Allergy Relief and Childrens Zyrtec(R) Chewable Tablets for Hives Relief
3. Forest Laboratories, Inc. and Merz Pharma GmbH & Co. KgaA File Lawsuits Against Several Companies for Patent Infringement
4. Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2008 Third Quarter Earnings
5. Roxane Laboratories, Inc. Announces the Launch of Granisetron Hydrochloride Tablets, 1mg
6. Roxane Laboratories, Inc. Announces the Launch of Balsalazide Disodium Capsules, 750mg
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic OTC Versions of Zyrtec Allergy Tablets(R) and Zyrtec Hives Relief Tablets(R)
8. Bond Laboratories, Inc. Announces 2-for-1 Forward Split
9. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Norvasc(R)
10. Caraco Pharmaceutical Laboratories, Ltd. Announces Tentative FDA Approval for Generic Lexapro(R)
11. Getting Ready Corporation and Winston Laboratories, Inc. Announce Merger Agreement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... CA (PRWEB) , ... January 19, 2017 , ... ... Health, is now offering treatments for patients with sleep apnea and TMJ disorders. ... for dental and physical health. Dr. Rassouli provides personalized care to reduce the ...
(Date:1/19/2017)... ... January 19, 2017 , ... Sam & Associates Insurance Agency, a full ... clients in the California Bay Area, is launching a charity drive to raise awareness ... Heart disease is the primary killer of adult men and women in America, and ...
(Date:1/19/2017)... ... January 19, 2017 , ... St. Catherine’s Village announced that a limited ... a skilled nursing facility on the grounds of the St. Catherine’s Village campus in ... voted the best nursing home in Mississippi for the second year in a row ...
(Date:1/19/2017)... ... , ... The CHP suggests that California drivers can avoid hydroplaning as well ... increasing the space between themselves and other vehicles, according to a January 3 ... Hassanlou notes that, rain or shine, drivers should always incorporate safe driving practices in ...
(Date:1/19/2017)... ... , ... Sales Focus Inc. (SFI), a Maryland-based sales outsourcing company, announced today ... past 20 years SFI has been recognized as the world’s leader in Intelligent Sales ... the US market. The new clients include: Panacea Pro, Campseekers, Contentmart, Stress Pal, ...
Breaking Medicine News(10 mins):
(Date:1/18/2017)... SAINT PAUL, Minn. , Jan. 18, 2017 ... the developer of medical devices using neuroblocking technology ... disorders, today announced the pricing of an underwritten ... $16.5 million, prior to deducting underwriting discounts and ... The offering is comprised of Class A ...
(Date:1/18/2017)... -- Adaptive Sound Technologies, Inc. (ASTI), the leading supplier of ... Place Nashville/Downtown to deliver the best sleep experience for ... in over two hundred of its guest rooms. ... having a great stay is sleeping well," said ... "We,re pleased to be able to offer our guests ...
(Date:1/18/2017)... SAN DIEGO , Jan. 18, 2017 /PRNewswire/ ... and innovative products to treat a variety of ... its lead compound DMT210, in a Phase 2 ... specifically developed to downregulate the proinflammatory cytokines in ... seen in acne rosacea. This ...
Breaking Medicine Technology: